Predictive Value of Max’s Giant Associated Protein Mutation in Outcomes of Lung Adenocarcinoma Patients Treated With Immune Checkpoint Inhibitors

Predictive Value of Max’s Giant Associated Protein Mutation in Outcomes of Lung Adenocarcinoma Patients Treated With Immune Checkpoint Inhibitors

Treatment with immune checkpoint inhibitors (ICIs) has considerably improved prognosis in multiple cancers. However, regardless of PD-L1 expression and TMB, better predictive biomarkers are required to identify ICI-responsive patients. We analyzed a pan-cancer cohort as the discovery cohort to ident...

Full description

Bibliographic Details
Main Authors: Yan Qu, Chao Wang, Lihui Liu, Sini Li, Xue Zhang, Zixiao Ma, Hua Bai, Jie Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
MGA mutation
pan-cancer
lung adenocarcinoma
immunotherapy
predictive biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.728647/full

Internet

https://www.frontiersin.org/articles/10.3389/fcell.2021.728647/full

Similar Items